Administrative Core
行政核心
基本信息
- 批准号:10364709
- 负责人:
- 金额:$ 32万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-03-15 至 2024-02-29
- 项目状态:已结题
- 来源:
- 关键词:Advisory CommitteesAnnual ReportsAntimicrobial ResistanceAreaAwardBacterial InfectionsBaltimoreCollaborationsCommunicationComplexContractsDataDevelopmentDiseaseDoctor of MedicineEnsureEvaluationEvaluation ResearchFosteringGeographyGoalsGrantGroup MeetingsInfrastructureInstitutionIntellectual PropertyLeadLeadershipMarylandMissionMonitorMulti-Drug ResistanceMyronOutcomePreventionPrincipal InvestigatorProgress ReportsPublicationsRegulationResearchResearch PersonnelResearch Project GrantsResource SharingResourcesScheduleSiteStructureSupervisionTimeTranslational ResearchTravelU-Series Cooperative AgreementsUnited States National Institutes of HealthUniversitiesVaccinationVaccinesWorkcollaborative environmentdata sharingexperienceflexibilitymeetingsoperationpassive antibodiespathogenic bacteriapreventproduct developmentprogramsresearch and developmentsymposiumsynergismtransmission processvaccine development
项目摘要
CETR Administrative Core ABSTRACT
The key role of the Administrative Core of the University of Maryland, Baltimore's Center of Excellence for
Translational Research (CETR) is to organize, manage comprehensively, facilitate, evaluate and supervise
investigators and institutions to ensure highly productive research efforts. A key mission of this Administrative
Core is to maintain a stable centralized, yet flexible and responsive, infrastructure to promote and harmonize
the research and product development activities towards the prevention of multidrug-resistant bacterial
diseases. Responsibilities of the CETR Administrative Core will include, but are not limited to: 1) facilitating
communications amongst the Research Projects and the Principal Investigator; 2) scheduling group meetings
and conferences; 3) management of program-related travel (including travel for the annual meeting); 4) annual
reporting; 5) organizing presentations and publication of data; 6) creation and implementation of administrative
and leadership mechanisms to foster effective interactions among investigators; 7) development and
implementation of a CETR evaluation plan; 8) identifying and resolving problems and unexpected outcomes; 9)
resource sharing and transmission of information and materials; 10) facilitating the timely release of research
findings and sharing of data per the NIH data sharing plan; 11) allocating and reallocating resources to meet
program goals; 12) tracking and prioritizing fiscal and other resources; and 13) compliance with federal and
NIH regulations.
The CETR Administrative Core will be led by its Principal Investigator and Director, Myron M. Levine,
M.D., D.T.P.H., who will oversee coordination efforts among the five Research Projects and will work to foster
a strong collaborative environment. He will be responsible for monitoring all research and for overseeing the
implementation of each project's Product Development Strategy. He will share his experience in vaccine
product development and will provide guidance to each of the projects in this area. Additionally, a Scientific
Advisory Committee will be composed of three parts; the Executive Committee, Regulatory Experts, and the
External Advisory Board. Together they will interact with and support the Principal Investigator in the overall
management and evaluation of all research and product development activities.
Over the past five years, the same administrative team at the Center for Vaccine Development at the
University of Maryland, Baltimore has successfully managed the previous U19 CETR award (Dr. Levine, PI). In
addition, the administrative team has served as the lead for many other multi-site, multi-project grants and
cooperative agreements. The breadth and depth of experience over such a diverse group of grants and
contracts is indicative of the proficiencies of this highly competent Administrative Core, which is poised to
manage the CETR.
CETR 行政核心 摘要
马里兰大学巴尔的摩卓越中心行政核心的关键作用
转化研究(CETR)是组织、综合管理、促进、评估和监督
研究人员和机构,以确保高效的研究工作。本次行政管理的一项重要任务
核心是维持一个稳定的、集中的、灵活的、反应灵敏的基础设施,以促进和协调
预防多重耐药细菌的研究和产品开发活动
疾病。 CETR 行政核心的职责包括但不限于: 1) 促进
研究项目和首席研究员之间的沟通; 2)安排小组会议
和会议; 3)项目相关差旅管理(包括年会差旅); 4) 年度
报告; 5)组织演示和发布数据; 6)行政管理的建立和实施
促进调查人员之间有效互动的领导机制; 7)开发和
实施 CETR 评估计划; 8)识别并解决问题和意外结果; 9)
信息、资料的资源共享和传输; 10)促进研究成果的及时发布
根据 NIH 数据共享计划发现和共享数据; 11)分配和重新分配资源以满足
计划目标; 12)跟踪财政和其他资源并确定其优先顺序; 13) 遵守联邦和
美国国立卫生研究院法规。
CETR 行政核心将由其首席研究员兼主任 Myron M. Levine 领导,
M.D.、D.T.P.H.,他将监督五个研究项目之间的协调工作,并将努力促进
强大的协作环境。他将负责监督所有研究并监督
实施每个项目的产品开发策略。他将分享他在疫苗方面的经验
产品开发并将为该领域的每个项目提供指导。此外,还有一个科学的
咨询委员会将由三部分组成;执行委员会、监管专家和
外部顾问委员会。他们将共同与首席研究员互动并提供总体支持
管理和评估所有研究和产品开发活动。
在过去的五年里,疫苗开发中心的同一管理团队
马里兰大学巴尔的摩分校成功管理了之前的 U19 CETR 奖项(Levine 博士,PI)。在
此外,管理团队还领导了许多其他多地点、多项目赠款和
合作协议。在如此多样化的资助群体中获得的经验的广度和深度
合同表明了这个高度称职的行政核心的熟练程度,它准备
管理 CETR。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Myron Max Levine其他文献
Myron Max Levine的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Myron Max Levine', 18)}}的其他基金
Active Vaccination and Passive Antibody Strategies to Prevent Disease Caused by Multidrug-Resistant Bacterial Pathogens
主动疫苗接种和被动抗体策略预防多重耐药细菌病原体引起的疾病
- 批准号:
10584474 - 财政年份:2019
- 资助金额:
$ 32万 - 项目类别:
Active Vaccination and Passive Antibody Strategies to Prevent Disease Caused by Multidrug-Resistant Bacterial Pathogens
主动疫苗接种和被动抗体策略预防多重耐药细菌病原体引起的疾病
- 批准号:
10364708 - 财政年份:2019
- 资助金额:
$ 32万 - 项目类别:
Active Vaccination and Passive Antibody Strategies to Prevent Disease Caused by Multidrug-Resistant Bacterial Pathogens
主动疫苗接种和被动抗体策略预防多重耐药细菌病原体引起的疾病
- 批准号:
9893801 - 财政年份:2019
- 资助金额:
$ 32万 - 项目类别:
Immunoprophylactic Strategies to Control Emerging Enteric Infections
控制新发肠道感染的免疫预防策略
- 批准号:
8803292 - 财政年份:2014
- 资助金额:
$ 32万 - 项目类别:
Immunoprophylactic Strategies to Control Emerging Enteric Infections
控制新发肠道感染的免疫预防策略
- 批准号:
9232995 - 财政年份:2014
- 资助金额:
$ 32万 - 项目类别:
Immunoprophylactic Strategies to Control Emerging Enteric Infections
控制新发肠道感染的免疫预防策略
- 批准号:
8642251 - 财政年份:2014
- 资助金额:
$ 32万 - 项目类别:
Immunoprophylactic Strategies to Control Emerging Enteric Infections
控制新发肠道感染的免疫预防策略
- 批准号:
9447098 - 财政年份:2014
- 资助金额:
$ 32万 - 项目类别:
相似海外基金
Therapeutic Agents Targeting Cryptococcal Infections
针对隐球菌感染的治疗药物
- 批准号:
10697960 - 财政年份:2023
- 资助金额:
$ 32万 - 项目类别:
Therapeutic Agents Targeting Cryptococcal Infections
针对隐球菌感染的治疗药物
- 批准号:
10697960 - 财政年份:2023
- 资助金额:
$ 32万 - 项目类别:
Selective proteasome inhibitors for trichomoniasis
滴虫病的选择性蛋白酶体抑制剂
- 批准号:
9806764 - 财政年份:2019
- 资助金额:
$ 32万 - 项目类别: